CTNM
Price:
$15.27
Market Cap:
$574.47M
Contineum Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing of small molecules different therapies for neuroscience, inflammation, and immunology indications in the United States. The company’s lead asset is PIPE-791, a novel, brain penetrant, small molecule inhibitor of the lysophosphatidic acid 1 receptor (LPA1R) for the treatment of idiopathic pulmonary fibrosis and chronic pain. It also develops PIPE-307, a novel, small-molecule inhibitor of the muscarinic type 1 receptor for depression and relapse-remitting multiple sclerosis. The company was formerly known as Pipeline Therapeutics, Inc. and changed its name to Contineum Therapeutics, Inc. in November...[Read more]
Industry
Biotechnology
IPO Date
2024-04-04
Stock Exchange
NASDAQ
Ticker
CTNM
According to Contineum Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Contineum Therapeutics, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), CTNM's Dividend Yield was at its highest in in the December 2022 quarter at 0%. The Dividend Yield was at its lowest in in the December 2022 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of Contineum Therapeutics, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
| Year | Dividend Yield | Change |
|---|---|---|
| 2025 | 0% | 0% |
| 2024 | 0% | 0% |
| 2023 | 0% | 0% |
| 2022 | 0% | 0% |
The current Dividend Yield of Contineum Therapeutics, Inc. (CTNM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
Contineum Therapeutics, Inc.’s Dividend Yield is less than Mereo BioPharma Group plc (0%), less than Kyverna Therapeutics, Inc. (0%), less than Lexeo Therapeutics, Inc. Common Stock (0%), less than Silence Therapeutics plc (0%), less than AC Immune S.A. (0%), less than Alto Neuroscience, Inc. (0%), less than Aldeyra The (0%), less than Capricor Therapeutics, Inc. (0%), less than Candel Therapeutics, Inc. (0%), less than Amarin Corporation plc (0%),
| Company | Dividend Yield | Market cap |
|---|---|---|
| 0% | $48.44M | |
| 0% | $464.48M | |
| 0% | $349.42M | |
| 0% | $530.91M | |
| 0% | $233.06M | |
| 0% | $981.93M | |
| 0% | $96.51M | |
| 0% | $227.59M | |
| 0% | $766.41M | |
| 0% | $298.04M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Contineum Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Contineum Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Contineum Therapeutics, Inc.'s Dividend Yield?
How is the Dividend Yield calculated for Contineum Therapeutics, Inc. (CTNM)?
What is the highest Dividend Yield for Contineum Therapeutics, Inc. (CTNM)?
What is the 3-year average Dividend Yield for Contineum Therapeutics, Inc. (CTNM)?
What is the 5-year average Dividend Yield for Contineum Therapeutics, Inc. (CTNM)?
How does the current Dividend Yield for Contineum Therapeutics, Inc. (CTNM) compare to its historical average?